Reperfusion is mandatory to salvage ischaemic myocardium from infarction, but also induces additional reperfusion injury and contributes to infarct size (IS). Gentle reperfusion (GR) has been proposed to attenuate reperfusion injury, but this remains contentious. We now investigated whether (i) GR reduces IS and (ii) GR is associated with the activation of reperfusion injury salvage kinases (RISK).
Introduction
Reperfusion is mandatory to salvage ischaemic myocardium from infarction. However, reperfusion itself induces additional damage, i.e. reperfusion injury. 1 Such reperfusion injury can be attenuated by modification of reperfusion. Ischaemic postconditioning (PoCo) by brief episodes of intermittent coronary re-occlusion during early reperfusion reduces infarct size (IS) 2 and was confirmed in all species tested so far, 3, 4 including humans 5, 6 (for review see Skyschally et al.
7
).
The activation of 'reperfusion injury salvage kinases' (RISK), i.e. phosphatidylinositol 3 kinase/protein kinase B (PI3K -AKT), 8, 9 mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK1/2-ERK1/2), 10 p70 ribosomal S6 protein kinase (p70S6K), and glycogen synthase kinase-3b (GSK3b), was proposed to be causal for the protection by ischaemic PoCo. 8 -12 The parallel signalling pathways of AKT and ERK1/2 converge on p70S6K and ultimately on GSK3b. Phosphorylation of GSK3b reduces mitochondrial permeability transition pore (mPTP) opening and promotes mitochondrial and cardiomyocyte survival. 13 However, recent studies questioned the importance of RISK for cardioprotection by PoCo and revealed that increased RISK phosphorylation was not necessarily associated with IS reduction 14 and, conversely, that IS reduction occurred without increased phosphorylation of AKT 10 or the entire RISK program; also, blockade of RISK did not attenuate the protection by PoCo. 15 Long before the first description of PoCo, gentle reperfusion (GR) was known to attenuate damage after ischaemia. 16 -20 However, whether IS was reduced by GR remained controversial. IS was reduced by GR in dogs with staged reperfusion at a perfusion pressure of less than 50 mmHg for 20 min. 16 Also, IS was reduced in dogs by GR when a coronary occluder was slowly released over 30 min, 19 but this was not confirmed in another study using a similar protocol. 20 In isolated, saline-perfused rat hearts, reperfusion at reduced perfusion pressure once more reduced IS, 21 -23 and this protection involved inhibition of mPTP opening. 21 Whether GR involves RISK as a signalling pathway is entirely unclear. Therefore, we have now investigated whether (i) GR reduces IS in pigs and (ii) GR is signalled through RISK phosphorylation.
The pig model was chosen, because species differences between small rodents and larger animals are an issue in protection against reperfusion injury, 7,15 and because pigs closely resemble the human heart with regard to size, coronary anatomy, heart rate, innate low collateral flow, and spatial and temporal development of myocardial infarction. Low-flow ischaemia rather than complete coronary occlusion was chosen (i) to retain some residual blood flow during ischaemia, which is present also in humans with a developed collateral perfusion and (ii) to avoid an excessive amount of arrhythmias and loss of animals. A causal role of RISK activation in IS reduction by GR was also addressed by blocking the main RISK pathways PI3 -AKT and MEK1/2-ERK1/2 by combined intracoronary infusion of wortmannin and U0126 during reperfusion.
Methods
The experimental protocols were approved by the Bioethical Committee of the district of Düsseldorf, and the investigation conforms with the Guide for the Care and Use of Laboratory Animals published by NIH Publication 85-23, revised 1996.
The pigs were sedated using ketamine hydrochloride (25 mg/kg IM). Anaesthesia was induced by thiopental (12.5 mg/kg IV) and maintained using enflurane (1.5 -2%) with an oxygen/nitrous oxide mixture (40:60%).
We used our established open-chest pig model with controlled perfusion of the left anterior descending coronary artery (LAD) perfusion territory. 24 Minimal coronary arterial pressure was held above 75 mmHg by adjusting the roller pump to avoid hypoperfusion prior to ischaemia. Radioactive microspheres injected into the extracorporeal perfusion system were used to determine regional myocardial blood flow at baseline and at 5 min ischaemia. After 2 h reperfusion, infarcted tissue was delineated from viable tissue by triphenyl tetrazolium chloride (TTC) staining. The amount of infarcted tissue is calculated as percent of the area at risk, as defined by the microspheres technique, i.e. a regional myocardial blood flow greater than 0.25 mL/min/g at baseline. 25 
Experimental protocol I
Following baseline measurements of systemic haemodynamics and regional myocardial blood flow, pigs were subjected to 90 min LAD hypoperfusion at 10% of baseline flow and 120 min reperfusion. 
Experimental protocol II
GR and IFR were performed as in protocol I, except that the major upstream RISK pathways, PI3 -AKT and MEK1/2-ERK1/2, were blocked during reperfusion (BL-GR, n ¼ 3; BL-IFR, n ¼ 3). Intracoronary co-infusion of blocking agents, i.e. wortmannin, an inhibitor of PI3 kinase, 26 and U0126, an inhibitor of MEK1/2 27 (both Sigma-Aldrich, Steinheim, Germany), was started during the last 10 min of ischaemia and was continued up to the end of reperfusion. Dosage and application of blocking agents were described previously. 15 Effective blockade of AKT and ERK1/2 phosphorylation was confirmed in myocardial biopsies.
Western blot analysis
Tissue samples were homogenized in 1Â Cell lysis buffer (Cell Signaling, Beverly, MA, USA); and 20 mg proteins were electrophoretically separated on 10% SDS -PAGE and transferred to nitrocellulose membranes. After blocking, membranes were incubated with the following antibodies: Phospho-AKT (Ser473, Cell Signaling), AKT (Cell Signaling), phospho-ERK1/2 (Tyr204, Santa Cruz Biotechnology, Santa Cruz, CA, USA), ERK1/2 (R&D Systems, Minneapolis, MN, USA), phospho-GSK3b (Ser9, Cell Signaling), GSK3b (Cell Signaling), phospho-p70S6K (Thr421/Ser424, Cell Signaling), and p70S6K (Cell Signaling). After incubation with the respective secondary antibodies immunoreactive signals were detected by chemiluminescence and quantified with Scion Image software (Scion Corporation, Frederick, MD, USA). Immunoreactivities of phosphorylated kinases were normalized to those of the respective total kinases. There were no differences between IFR and GR in RISK phosphorylation at baseline. Therefore, baseline values were set as 100% and time courses of RISK phosphorylation within individual animals determined.
Data analysis and statistics
Data are reported as mean values + SEM. Differences in regional myocardial blood flow, area at risk, and IS were analysed by double sided t-tests. Systemic haemodynamics and time courses of RISK phosphorylation were analysed by two-way ANOVA (time, group). Fisher's least-significant difference tests were used for post hoc comparisons. A P-value 0.05 indicated a significant difference.
Results
In the present study, two animals died due to untreatable sustained ventricular fibrillation during ischaemia and one animal died during the first 30 min of reperfusion. These animals were excluded from further analysis. In protocol I, systemic haemodynamics at baseline and during ischaemia, area at risk, and subendocardial blood flow at 5 min ischaemia were not different between GR and IFR ( Tables 1 and 2 ( Table 1) . Phosphorylation of AKT, ERK1/2, and p70S6K tended to decrease at 85 min ischaemia, whereas phosphorylation of GSK3b tended to increase, without differences between GR and IFR. With IFR, the phosphorylation of all analysed kinases increased above baseline at 10 min reperfusion and remained elevated throughout 120 min reperfusion. With GR, the phosphorylation of AKT and GSK3b increased first at 30 min reperfusion, whereas ERK1/2 and p70S6K only tended to increase, and the phosphorylation of all kinases was back to baseline at 120 min reperfusion ( Figure 1) . In protocol II, systemic haemodynamics at baseline and during ischaemia, area at risk, and subendocardial blood flow at 5 min ischaemia were not different between BL-GR and BL-IFR (Tables 1 and 2) . IS was 27 + 4% with BL-GR and 42 + 5% (P , 0.05) with BL-IFR ( Table 1) . Phosphorylation of AKT, ERK1/2, and p70S6K was decreased at 85 min ischaemia, whereas phosphorylation of GSK3b tended to increase, without differences between GR and IFR. After RISK blockade, the phosphorylation of all analysed kinases remained then below baseline up to the end of reperfusion in both groups (Figure 2 ).
Discussion
The present study confirms IS reduction by GR which was previously contentious. 16,19 -21 When compared with an IS reduction by 50% with a PoCo protocol in the otherwise same experimental model, 15 the reduction by 20% (from 37 to 29% of area at risk) or 36% (from 42 to 27% of area at risk after pharmacological RISK blockade) with GR was only modest. This difference may be related to the more pronounced extension of ischaemia (inflow deficit) by the GR manoeuvre vs. that by a total of only 120 s coronary occlusion in the PoCo protocol. Alternatively, GR and PoCo may be mechanistically different procedures of modified reperfusion. However, when extrapolating our results to patients with myocardial infarction undergoing reperfusion, even a modest reduction in IS by 20% is associated with a 30% reduction in 6 months mortality. 28 In preliminary experiments, we tested different GR procedures, such as a linear increase of coronary inflow over 10 or 30 min, respectively. These procedures did not reduce IS. The algorithm used in the present study was adapted from a study by Sato et al. 19 in which successful IS reduction by GR was achieved in dogs. However, we cannot exclude that this GR algorithm was still suboptimal to achieve maximum IS reduction in our pig model. The present experiments were performed in an established anaesthetized open-chest pig model. When compared with conscious pigs, 29 heart rate (124-131 min 21 in conscious animals vs.
98 min 21 in the present study) and left ventricular peak pressure (107 mmHg in conscious animals vs. 95 mmHg in the present study) are somewhat depressed, but still better preserved than in pigs under opioid 30 or barbiturate anaesthesia. 31 On the technical side, in future studies, any delay or attenuation of full reperfusion must be avoided in the control group when the effects of protective manoeuvres such as PoCo or GR are studied because otherwise the extent of protection will be underestimated. 32 Mechanistically, inhibition of mPTP opening has been causally related to IS reduction by GR. 21 The RISK activation cascade also converges on inhibition of mPTP opening during PoCo. 33 However, the role of RISK activation during GR has not been addressed before. The role of RISK activation during PoCo is contentious. After a PoCo manoeuvre, phosphorylation of AKT and ERK1/2 was increased along with reduced troponin release in mice. 34 In pigs, the PoCo-induced increased phosphorylation of AKT and ERK1/2 was not associated with IS reduction. 14 Conversely, IS reduction occurred without increased phosphorylation of AKT, but only with increased phosphorylation of ERK1/2 in mice 35 and rabbits. 10 Pharmacological blockade of AKT phosphorylation abrogated protection by PoCo in rats 8 and rabbits, 12 but not in mice. 35 Experiments in genetically modified mice questioned the role of GSK3b in cardioprotection. 36 However, the results were in contrast to a prior study in the same strain of mice. 37 Therefore, an editorial caveat for the potential compensation by other mechanisms was voiced which might have precluded firm conclusions on the role of GSK3b in cardioprotection. 38 Unfortunately, a recent review did not critically weigh the pros and cons for a role of GSK3b in cardioprotection but was defensive of the authors' prior in vitro data and ignored the lack of effect of blockade of GSK3b, as evidenced by western blot analysis, on protection by PoCo in pigs, 15 but rather speculated on unsubstantiated problems with different commercial antibodies and again unsubstantiated species differences. 39 We have observed IS reduction along with the activation of the RISK kinases AKT, ERK1/2, p70S6K, and GSK3b in our present pig model with PoCo, but the RISK activation pattern was not different from that with IFR, and pharmacological blockade of RISK activation did not abrogate IS reduction by PoCo, thus excluding a causal role for RISK activation in PoCo in our model. 15 The present study also refutes a role for RISK activation in the protection by GR, since IS was reduced when the phosphorylation of RISK was actually lower than with IFR during early reperfusion, and blockade of RISK did not attenuate IS reduction by GR. The somewhat larger IS in BL-IFR than in IFR is attributed to a lower ischaemic subendocardial blood in BL-IFR than IFR ( Table 1) . At 10 min reperfusion with GR, the phosphorylation levels of RISK kinases remained near levels measured during ischaemia and were still lower than baseline for AKT and ERK1/2. Admittedly, RISK phosphorylation increased also with GR when reperfusion was fully restored at 30 min, but this late increase still remained below phosphorylation with IFR. An increase in RISK phosphorylation beyond 30 min is unlikely to contribute to myocardial protection, since IS determined by TTC staining does not change appreciably when reperfusion is extended beyond 30 min 40 and there appears to be consensus that protection against reperfusion injury must be initiated during the immediate onset of reperfusion. 7 As already observed with PoCo, the pharmacological blockade of RISK activation did not impact on IS reduction by GR, excluding again a causal role of RISK activation for protection against infarction. Nevertheless, species differences between rodents and pigs are not excluded by our study and might be a reason for the observed differences in the role of RISK in myocardial protection at reperfusion. Alternative mechanism(s) that may ultimately inhibit mPTP opening 21 may involve a reduction in reactive oxygen species formation and calcium overload, but maintenance of acidosis into early reperfusion. 41 -43 Alternatively, other signalling pathways may also Gentle reperfusion without RISK activation be causally involved, such as the JAK-STAT pathway, 44 -46 which is essential to PoCo 47 and TNFa-induced 45, 46 cardioprotection, 4 and endogenous TNFa is also protective in the present model following coronary microembolization. 24 Clearly, GR reduces IS by 20-36%, and IS is the major determinant of prognosis in patients with myocardial infarction. 48 No matter whether GR and PoCo are mechanistically distinct phenomena or just different procedures of modified reperfusion, increased RISK activation is not mandatory to achieve protection from reperfusion injury.
